Responses
Epidemiology
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.